Back to feed
Induction and concurrent aumolertinib with radiotherapy for EGFR-mutated stage III NSCLC: results of phase III ADVANCE trial and real-world validation
Read the full article at nature-health#induction#concurrent#aumolertinib#radiotherapy#egfrmutated#stage#nsclc#results#phase#advance
to like, bookmark, and comment.
Save Collection
Comments
Join the conversation:
No comments yet. Be the first to share your thoughts.